Blood component therapy: Which, when and how much
- PMID: 21772701
- PMCID: PMC3127320
- DOI: 10.4103/0970-9185.81849
Blood component therapy: Which, when and how much
Abstract
Blood transfusion refers to the perioperative administration of blood and blood components. Adherence to proper indications for blood component therapy is essential because of its potential adverse effects and costs of transfusion. Over the years, the significance of blood components in treating certain diseases or conditions has been recognized. In this article, the most commonly used blood components along with the new developments in component therapy have been discussed. Recommendations by different academic and clinical trials and studies have been presented for quick reference. The individual coagulation factors are discussed in brief.
Keywords: Blood transfusion; bleeding disorder; blood components; coagulopathy.
Conflict of interest statement
References
-
- Practice Guidelines for Perioperative Blood Transfusion and Adjuvant Therapies: An Updated Report by the American Society of Anesthesiologists Task Force on Perioperative Blood Transfusion and Adjuvant Therapies. Anesthesiology. 2006;105:198–208. - PubMed
-
- Stehling L, Luban NL, Anderson KC, Sayers MH, Long A, Attar S, et al. Guidelines for blood utilization review. Transfusion. 1994;34:438–48. - PubMed
-
- Despotis GJ, Grishaber JE, Goodnough LT. The effect of an intraoperative treatment algorithm on physicians′ transfusion practice in cardiac surgery. Transfusion. 1994;34:290–6. - PubMed
-
- Paone G, Spencer T, Silverman NA. Blood conservation in coronary artery surgery. Surgery. 1994;116:672–8. - PubMed
-
- Wallace EL, Surgenor DM, Hao HS, An J, Chapman RH, Churchill WH. Collection and transfusion of blood and blood components in the United States, 1989. Transfusion. 1993;33:139–44. - PubMed
LinkOut - more resources
Full Text Sources
Medical
